WST
NYSE HealthcareWest Pharmaceutical Services, Inc. Common Stock
Medical Instruments & Supplies
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.
๐ Market Data
| Price | $362.44 |
|---|---|
| Volume | 544,363 |
| Market Cap | 25.61B |
| Dividend Yield % | 0.25% |
| Beta | 1.160 |
| RSI (14-Day) | 65.3 |
| 200-Day MA | $280.27 |
| 50-Day MA | $330.59 |
| 52-Week High | $367.66 |
| 52-Week Low | $206.80 |
| P/E Ratio | 48.52 |
| Forward P/E | 37.68 |
| Price / Book | 8.59 |
๐ฏ Investment Strategy Scores
WST scores across each investment strategy. Higher is better for that strategy's goals.
๐ Strategy Interpretation
Best fit: ๐ Institutional Whale (84/100) โ this strategy Large-cap, institutional-quality stocks.
Lowest fit among scored strategies: ๐ช Falling Knife (12/100). No single score is a buy or sell signal โ use multiple lenses together. Learn how to read these scores โ
๐ Learn More
Indicators on this page
Educational articles
Find WST in your text
Paste any article, transcript, or post โ the tool will extract WST and every other hidden ticker.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-07-16.